News

Press Releases

Media Resources

Media contact:

Michelle McAdam
Chronic Communications, Inc.
michelle@chronic-comm.com
(310) 902-1274

DynamX transparent

3300 px x 875 px
PNG

DynamX Blue Background

3840 px x 2160 px
PNG

DynamX Alone

1920 x 1080
MP4

DynamX In Vessel

1920 x 1080
MP4

PMN 574 Rev A
Elixir-Medical-Corporation-Coronary-Device

Corporate Headquarters
920 N. McCarthy Blvd
Milpitas, CA 95035 U.S.
+1.408.636.2000
info@elixirmedical.com

Elixir, Innovation for Life and DESyne are registered trademarks, and DynamX a trademark, in the US and internationally for Elixir Medical Corporation.
DynamX Coronary Bioadaptor System and DESyne X2 Novolimus Eluting Coronary Stent System are CE Mark approved.
©2020 Elixir Medical. All rights reserved.
International (OUS) Use Only. DynamX and DESyne X2 are intended to improve coronary luminal diameter in patients with symptomatic ischemic heart disease due to discrete de novo native coronary artery lesions. CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device.

Sign up to receive news and information about Elixir Medical, our products and other relevant information as it becomes available.